Terms: = Breast cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Diagnosis
66 results:
1. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report.
Gan J; Liu M; Liu F; Wen J; Fu W; Jia J
BMC Pulm Med; 2024 Feb; 24(1):93. PubMed ID: 38388422
[TBL] [Abstract] [Full Text] [Related]
2. Superbinder based phosphoproteomic landscape revealed PRKCD_pY313 mediates the activation of Src and p38 MAPK to promote TNBC progression.
Deng Y; Hou Z; Li Y; Yi M; Wu Y; Zheng Y; Yang F; Zhong G; Hao Q; Zhai Z; Wang M; Ma X; Kang H; Ji F; Dong C; Liu H; Dai Z
Cell Commun Signal; 2024 Feb; 22(1):115. PubMed ID: 38347536
[TBL] [Abstract] [Full Text] [Related]
3. Nanotechnology-mediated delivery of resveratrol as promising strategy to improve therapeutic efficacy in triple negative breast cancer (TNBC): progress and promises.
Ahmad J; Ahamad J; Algahtani MS; Garg A; Shahzad N; Ahmad MZ; Imam SS
Expert Opin Drug Deliv; 2024 Feb; 21(2):229-244. PubMed ID: 38344809
[TBL] [Abstract] [Full Text] [Related]
4. Tumour 63 protein (p63) in breast pathology: biology, immunohistochemistry, diagnostic applications, and pitfalls.
Alkhayyat R; Abbas A; Quinn CM; Rakha EA
Histopathology; 2024 Apr; 84(5):723-741. PubMed ID: 38012539
[TBL] [Abstract] [Full Text] [Related]
5. Digital Papillary Adenocarcinoma in Nonacral Skin: Clinicopathologic and Genetic Characterization of 5 Cases.
Kervarrec T; Imbeaud S; Veyer D; Pere H; Puech J; Pekár-Lukacs A; Markiewicz D; Coutts M; Tallet A; Collin C; Berthon P; Bravo IG; Seris A; Jouary T; Macagno N; Touzé A; Cribier B; Battistella M; Calonje E
Am J Surg Pathol; 2023 Oct; 47(10):1077-1084. PubMed ID: 37505796
[TBL] [Abstract] [Full Text] [Related]
6. Adamantinoma-Like Ewing Sarcoma Mimicking Merkel Cell Carcinoma in the Parotid Gland: A Diagnostic Pitfall.
Saikia K; Alruwaii FI; Wu V; Keller C; Chitale D; Al-Obaidy KI
Int J Surg Pathol; 2024 Feb; 32(1):115-118. PubMed ID: 37128815
[TBL] [Abstract] [Full Text] [Related]
7. Ribosome Biogenesis Regulator 1 Homolog (RRS1) Promotes Cisplatin Resistance by Regulating AEG-1 Abundance in breast cancer Cells.
Song J; Peng C; Wang R; Hua Y; Wu Q; Deng L; Cao Y; Zhang L; Hou L
Molecules; 2023 Mar; 28(7):. PubMed ID: 37049702
[TBL] [Abstract] [Full Text] [Related]
8. N6-Methyladenosine-Mediated Up-Regulation of FZD10 Regulates Liver cancer Stem Cells' Properties and Lenvatinib Resistance Through WNT/β-Catenin and Hippo Signaling Pathways.
Wang J; Yu H; Dong W; Zhang C; Hu M; Ma W; Jiang X; Li H; Yang P; Xiang D
Gastroenterology; 2023 May; 164(6):990-1005. PubMed ID: 36764493
[TBL] [Abstract] [Full Text] [Related]
9. cancer-associated fibroblasts facilitate premetastatic niche formation through lncRNA SNHG5-mediated angiogenesis and vascular permeability in breast cancer.
Zeng H; Hou Y; Zhou X; Lang L; Luo H; Sun Y; Wan X; Yuan T; Wang R; Liu Y; Tang R; Cheng S; Xu M; Liu M
Theranostics; 2022; 12(17):7351-7370. PubMed ID: 36438499
[No Abstract] [Full Text] [Related]
10. MIR4435-2HG Is a Potential Pan-cancer Biomarker for diagnosis and Prognosis.
Zhong C; Xie Z; Zeng LH; Yuan C; Duan S
Front Immunol; 2022; 13():855078. PubMed ID: 35784328
[TBL] [Abstract] [Full Text] [Related]
11. Emerging role of LINC00461 in cancer.
Zhang Q; Zhong C; Shen J; Chen S; Jia Y; Duan S
Biomed Pharmacother; 2022 Aug; 152():113239. PubMed ID: 35679722
[TBL] [Abstract] [Full Text] [Related]
12. Long noncoding RNA GK-IT1 promotes esophageal squamous cell carcinoma by regulating mapk1 phosphorylation.
Yang X; Zeng T; Liu Z; He W; Hu M; Tang T; Chen L; Xing L
Cancer Med; 2022 Dec; 11(23):4555-4574. PubMed ID: 35608100
[TBL] [Abstract] [Full Text] [Related]
13. [Primary lung salivary gland-type duct carcinoma: a clinicopathological analysis of two cases and review of literature].
Li SL; Wu CY; Hou LK; Xie HK; Wu W; Zhang W; Zhang LP
Zhonghua Bing Li Xue Za Zhi; 2022 Mar; 51(3):218-223. PubMed ID: 35249285
[No Abstract] [Full Text] [Related]
14. Semaphorin 3D inhibits proliferation and migration of papillary thyroid carcinoma by regulating MAPK/erk signaling pathway.
Hai R; You Q; Wu F; Qiu G; Yang Q; Shu L; Xie L; Zhou X
Mol Biol Rep; 2022 May; 49(5):3793-3802. PubMed ID: 35190928
[TBL] [Abstract] [Full Text] [Related]
15. Expression of hypoxia inducible factor-dependent neuropeptide Y receptors Y1 and Y5 sensitizes hypoxic cells to NPY stimulation.
Medeiros PJ; Pascetta SA; Kirsh SM; Al-Khazraji BK; Uniacke J
J Biol Chem; 2022 Mar; 298(3):101645. PubMed ID: 35093384
[TBL] [Abstract] [Full Text] [Related]
16. Prostate cancer dormancy and recurrence.
Cackowski FC; Heath EI
Cancer Lett; 2022 Jan; 524():103-108. PubMed ID: 34624433
[TBL] [Abstract] [Full Text] [Related]
17. Dysfunction of miR-802 in tumors.
Gao T; Zou M; Shen T; Duan S
J Clin Lab Anal; 2021 Nov; 35(11):e23989. PubMed ID: 34558723
[TBL] [Abstract] [Full Text] [Related]
18. Kinesin 12 (KIF15) contributes to the development and tumorigenicity of prostate cancer.
Qureshi Z; Ahmad M; Yang WX; Tan FQ
Biochem Biophys Res Commun; 2021 Oct; 576():7-14. PubMed ID: 34474246
[TBL] [Abstract] [Full Text] [Related]
19. Primary Extra-Osseous Ewing Sarcoma of the Thyroid: A Case Report and Review of the Literature.
Seipel AH; Mechahougui H; Mach N; Triponez F; Faquin WC; De Vito C
Head Neck Pathol; 2022 Jun; 16(2):581-586. PubMed ID: 34312795
[TBL] [Abstract] [Full Text] [Related]
20. The CDCP1 Signaling Hub: A Target for cancer Detection and Therapeutic Intervention.
Khan T; Kryza T; Lyons NJ; He Y; Hooper JD
Cancer Res; 2021 May; 81(9):2259-2269. PubMed ID: 33509939
[TBL] [Abstract] [Full Text] [Related]
[Next]
